{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "messageBoardId": "finmb_24349026", "regularMarketChangePercent": 3.5842345, "regularMarketPrice": 2.89, "exchange": "NCM", "shortName": "Eterna Therapeutics Inc.", "longName": "Eterna Therapeutics Inc.", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "firstTradeDateMilliseconds": 683472600000, "priceHint": 4, "regularMarketChange": 0.10000014, "regularMarketTime": 1684180259, "regularMarketDayHigh": 2.92, "regularMarketDayRange": "2.76 - 2.92", "regularMarketDayLow": 2.76, "regularMarketVolume": 7597, "regularMarketPreviousClose": 2.79, "bid": 0.0, "ask": 0.0, "bidSize": 8, "askSize": 14, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 2.88, "averageDailyVolume3Month": 7201, "averageDailyVolume10Day": 11690, "fiftyTwoWeekLowChange": 0.1500001, "fiftyTwoWeekLowChangePercent": 0.05474456, "fiftyTwoWeekRange": "2.74 - 17.6", "fiftyTwoWeekHighChange": -14.71, "fiftyTwoWeekHighChangePercent": -0.83579546, "fiftyTwoWeekLow": 2.74, "fiftyTwoWeekHigh": 17.6, "earningsTimestamp": 1679343000, "earningsTimestampStart": 1679343000, "earningsTimestampEnd": 1679343000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -7.44, "epsForward": -9.6, "sharesOutstanding": 5270070, "bookValue": 2.361, "fiftyDayAverage": 3.2592, "fiftyDayAverageChange": -0.3692, "fiftyDayAverageChangePercent": -0.11327933, "twoHundredDayAverage": 4.7239, "twoHundredDayAverageChange": -1.8338997, "twoHundredDayAverageChangePercent": -0.38821733, "marketCap": 16495138, "forwardPE": -0.30104166, "priceToBook": 1.2240577, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "NTN Buzztime, Inc", "nameChangeDate": "2023-05-15", "averageAnalystRating": "3.0 - Hold", "tradeable": false, "cryptoTradeable": false, "displayName": "Eterna Therapeutics", "symbol": "ERNA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1035 Cambridge Street", "address2": "Suite 18A", "city": "Cambridge", "state": "MA", "zip": "02141", "country": "United States", "phone": "212 582 1199", "website": "https://eternatx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Eterna Therapeutics Inc., a preclinical-stage, biopharmaceutical company. The company offers Synthetic mRNA, ToRNAdo mRNA Delivery, mRNA Gene Editing, and mRNA Cell Reprogramming. It also develops therapies and medicines using gene-editing proteins and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. The company was formerly known as and changed its name to Eterna Therapeutics Inc. in October 2022. Eterna Therapeutics Inc. is based in Cambridge, Massachusetts.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Matthew  Angel Ph.D.", "age": 40, "title": "CEO, Pres & Director", "yearBorn": 1982, "fiscalYear": 2022, "totalPay": {"raw": 240801, "fmt": "240.8k", "longFmt": "240,801"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sandra M. Gurrola", "age": 55, "title": "Principal Financial & Accounting Officer and VP of Fin.", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Susan  McClatchey", "title": "VP & Head of Quality", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}